Summary
Home-Based Transcranial Direct Current Stimulation is tracked by OSMF as an investigational option for ME/CFS; no regulator has approved it for this indication, and most post-viral conditions have no approved disease-modifying therapy at all. ClinicalTrials.gov lists 1 registered trial linking Home-Based Transcranial Direct Current Stimulation to ME/CFS: 1 is active or not yet recruiting. None of the registered studies carries a drug-development phase label, which is typical for behavioural, device and supplement protocols. It plans or enrolled 20 participants. Registered activity dates to 2023. The literature layer holds 12 publications for this pair: 12 PubMed search records. Publication years run from 2023 to 2026. Items here are search-derived or curated references rather than classified trial reports; treat them as leads to read, not as graded evidence.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome is tracked on the OSMF post-viral programme alongside ME/CFS, Long COVID, POTS and MCAS. Across the programme, 195 candidate agents are logged for ME/CFS, most of them preliminary; this page isolates the record for one of them.
Evidence table
| Evidence tier | C · Preliminary |
|---|---|
| Evidence score | 20.0 (trials 3.0, literature 12.0, tier 5, approved bonus 0.0) |
| Registered trials | 1 total: 0 recruiting, 1 active / not yet recruiting, 0 completed, 0 other |
| Linked publications | 12 (12 PubMed search records) |
| Agent type | Other (Other / Unclassified) |
| Development stage (any indication) | Investigational |
| Mechanism / class | Not recorded |
| Data sources | OSMF therapeutic agent database, ClinicalTrials.gov, PubMed |
How the evidence score is calculated
- Each registered trial scores by status (recruiting / active / enrolling 3, completed 2.5, not yet recruiting 2, unknown 1, terminated / withdrawn / suspended 0.5) plus a phase bonus (phase 3-4 +2, phase 2 +1, phase 1 +0.5). The trial component is capped at 30.
- Each literature item scores by design (Cochrane review 5, meta-analysis 4, systematic review 3, RCT 3, clinical trial publication 2, curated reference 1.5, other PubMed record 1). The literature component is capped at 30.
- The existing evidence tier adds 15 (A / Strong), 10 (B / Moderate), 5 (C / Preliminary) or 0 (D / Anecdotal).
- Agents approved for any indication (max clinical phase 4) add 5, because an approved agent has an established safety profile that lowers the barrier to repurposing trials.
- The score ranks what has been studied, not what works. It does not read effect sizes or directions of effect.
Registered clinical trials
| NCT ID | Title | Status | Phase | Enrolment |
|---|---|---|---|---|
| NCT05791812 | Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE University of Regensburg · 2023 | active, not recruiting | Not applicable | 20 |
Published literature
- PubMed record (biomarker-intervention search) Home-Based Transcranial Direct Current Stimulation for Menstrual Pain and Premenstrual Symptoms: A Randomized Controlled Trial.International journal of women's health · 2026 · PMID 42094870
- PubMed record (biomarker-intervention search) Effects of TDCS and TENS on chronic low back pain: A randomized controlled clinical trial.Journal of bodywork and movement therapies · 2026 · PMID 41927183
- PubMed record (biomarker-intervention search) Efficacy and Safety of Non-invasive Brain Stimulation in Non-migraine Primary Headache Disorders: A Systematic Review and Meta-analysis.Annals of Indian Academy of Neurology · 2026 · PMID 42831689
- PubMed record (biomarker-intervention search) Interventions for post-stroke cognitive impairment: a systematic review of neuroplastic mechanisms, comparative efficacy, and multimodal approaches.Frontiers in neuroscience · 2026 · PMID 42780258
- PubMed record (biomarker-intervention search) Transcranial direct current stimulation for learning and memory in Parkinson's disease: a systematic review.Frontiers in neuroscience · 2026 · PMID 42775214
- PubMed record (biomarker-intervention search) Transcranial direct current stimulation combined with rehabilitation training for chronic spinal pain: a systematic review and Meta-analysis.Frontiers in neurology · 2026 · PMID 42729325
- PubMed record (biomarker-intervention search) Efficacy of non-invasive brain stimulation for post-stroke depression: a systematic review and meta-analysis.Frontiers in psychology · 2026 · PMID 42723975
- PubMed record (biomarker-intervention search) Non-invasive brain stimulation in amyotrophic lateral sclerosis: a systematic review and meta-analysis of transcranial direct current stimulation and transcranial magnetic stimulation.Neurodegenerative disease management · 2026 · PMID 42721110
- PubMed record (biomarker-intervention search) Cognitive and neurophysiological effects of bilateral tDCS neuromodulation in patients with minimally conscious state.Scientific reports · 2025 · PMID 40274956
- PubMed record (biomarker-intervention search) Reduction of Chronic Fatigue Through Transcranial Direct Current Stimulation and Low-Intensity Aerobic Exercise: A Case Study of Two Patients With Granulomatosis With Polyangiitis.Cureus · 2024 · PMID 39712710
- PubMed record (biomarker-intervention search) The Impact of Stimulation Parameters on Cardiovascular Outcomes in Chronic Stroke Patients Following Transcranial Direct Current Stimulation-A Pilot Controlled, Randomized, Double-Blind Crossover Trial.Biomedicines · 2024 · PMID 39335512
- PubMed record (biomarker-intervention search) Anodal transcranial direct current stimulation associated with aerobic exercise on the functional and physical capacity of patients with heart failure with reduced ejection fraction: ELETRIC study protocol.Trials · 2023 · PMID 37974293
Mechanism and notes
No mechanism of action is recorded for this pair in the source databases.
Clinical notes: Investigational for listed conditions. 1 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing in studies: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Frequently asked questions
Is Home-Based Transcranial Direct Current Stimulation approved for ME/CFS?
Home-Based Transcranial Direct Current Stimulation is tracked by OSMF as an investigational option for ME/CFS; no regulator has approved it for this indication, and most post-viral conditions have no approved disease-modifying therapy at all. Approval status for the specific indication should always be confirmed with the relevant regulator and prescribing information.
Is Home-Based Transcranial Direct Current Stimulation in clinical trials for ME/CFS?
ClinicalTrials.gov lists 1 registered trial linking Home-Based Transcranial Direct Current Stimulation to ME/CFS: 1 is active or not yet recruiting. None of the registered studies carries a drug-development phase label, which is typical for behavioural, device and supplement protocols. It plans or enrolled 20 participants. Registered activity dates to 2023.
What does the evidence show for Home-Based Transcranial Direct Current Stimulation in ME/CFS?
Trials of Home-Based Transcranial Direct Current Stimulation in ME/CFS are registered but none has completed, so there is no outcome evidence from those studies yet; the record is a signal of research interest. OSMF's existing evidence tier for this pair is C (Preliminary), taken from the OSMF therapeutic agent database, which grades agents by the volume and design of condition-specific evidence rather than by effect size.
Cite this page
Data: ClinicalTrials.gov, PubMed, Open Targets, ChEMBL, DGIdb and the OSMF therapeutic agent database. Last updated 2026-11-22. Page built 2026-11-22.